- Home
- Companies
- usa california
- chest pain
Refine by
Chest Pain Suppliers In Usa California
5 companies found
based inIrvine, CALIFORNIA (USA)
JenaValve is a clinical-stage medical device company developing the first transcatheter heart valve technology that is uniquely designed for the minimally invasive treatment of both severe aortic regurgitation and stenosis. JenaValve is passionate ...
Aortic regurgitation (AR), also known as aortic insufficiency (AI), is a condition that occurs when your heart’s aortic valve doesn’t close tightly. Aortic regurgitation allows some of the blood that was pumped out of your heart’s ...
based inSan Diego, CALIFORNIA (USA)
We are here to understand our clients' challenges and give them a solution. We put our clients first, aiming to be an extension of their organizations. Since our beginning in 1999, we have become a leader in web-based solutions designed to simplify ...
TargetSolutions offers a comprehensive catalog of online EMS continuing education courses that is accepted in most states. Our courses allow first responders, EMT-Basics, EMT-Intermediates and EMT-Paramedics to complete their continuing education ...
based inSanta Clara, CALIFORNIA (USA)
Shockwave is focused on developing and commercializing products intended to transform the way calcified cardiovascular disease is treated. Shockwave aims to establish a new standard of care for the interventional treatment of atherosclerotic ...
Neovasc is focused on creating better outcomes for difficult-to-treat cardiology patients through the development of two novel products: Reducer™* for treatment of refractory angina and the Tiara™ System* for treatment of mitral valve ...
based inTorrance, CALIFORNIA (USA)
Emmaus Life Sciences, Inc. is a biopharmaceutical company engaged in the discovery, development and commercialization of innovative treatments and therapies primarily for rare and orphan diseases. Our initial efforts have focused on treatments for ...
ENDARI [L-glutamine oral powder] is indicated to reduce the acute complications of sickle cell disease in adults and children 5 years and ...
based inSan Rafael, CALIFORNIA (USA)
Established in 1997, BioMarin is a world leader in developing and commercializing first- or best-in-class therapies for rare genetic diseases. We take pride in going where the science leads us, pioneering breakthrough treatments for debilitating and ...
Vimizim (elosulfase alfa) is the first approved enzyme replacement therapy designed to address the underlying cause of Morquio A syndrome, or mucopolysaccharidosis IVA (MPS IVA) — a deficiency in the enzyme N-acetylgalactosamine-6 sulfatase ...